Can-Fite BioPharma Ltd.CANFNYSE
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+23.0%
5Y CAGR+4.4%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+23.0%/yr
Annual compound
5Y CAGR
+4.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.01 | +184.8% |
| 2023 | 0.00 | -40.0% |
| 2022 | 0.01 | +9.1% |
| 2021 | 0.01 | -13.0% |
| 2020 | 0.01 | -23.3% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |